US 12304968
T-cells expressing anti-LIV1 chimeric antigen receptor
granted A61KA61K2039/812A61K2039/868
Quick answer
US patent 12304968 (T-cells expressing anti-LIV1 chimeric antigen receptor) held by CRISPR THERAPEUTICS AG expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/812, A61K2039/868, A61K2239/49, A61K2239/56